These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Comparison different methods of intraoperative and intraperitoneal chemotherapy for patients with gastric cancer: a meta-analysis. Huang JY; Xu YY; Sun Z; Zhu Z; Song YX; Guo PT; You Y; Xu HM Asian Pac J Cancer Prev; 2012; 13(9):4379-85. PubMed ID: 23167347 [TBL] [Abstract][Full Text] [Related]
12. Safe handling of antineoplastic drugs. Harrison BR Top Hosp Pharm Manage; 1994 Jul; 14(2):1-10. PubMed ID: 10136200 [TBL] [Abstract][Full Text] [Related]
13. Safe handling of cytotoxic agents: a team approach. Willemsen-McBride T; Gehan K AORN J; 2009 Nov; 90(5):731-2, 735-40. PubMed ID: 19895929 [TBL] [Abstract][Full Text] [Related]
14. Introduction of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) to the surgery program. Small T ORNAC J; 2013 Jun; 31(2):12-7, 28-33. PubMed ID: 23957107 [TBL] [Abstract][Full Text] [Related]
15. Safety constiderations in the use of intraoperative intraperitoneal chemotherapy. White SK; Stephens AD; Dowjat B; Sugarbaker PH Cancer Treat Res; 1996; 82():311-6. PubMed ID: 8849958 [TBL] [Abstract][Full Text] [Related]
17. Techniques and Safety Issues for Intraperitoneal Chemotherapy. González-Moreno S; Ortega-Pérez G; Alonso-Casado O; Galipienzo-García J; Linero-Noguera MJ; Salvatierra-Díaz D Surg Oncol Clin N Am; 2018 Jul; 27(3):495-506. PubMed ID: 29935685 [TBL] [Abstract][Full Text] [Related]
18. Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis: clinical outcome and prognostic factors in 60 consecutive patients. Rossi CR; Deraco M; De Simone M; Mocellin S; Pilati P; Foletto M; Cavaliere F; Kusamura S; Gronchi A; Lise M Cancer; 2004 May; 100(9):1943-50. PubMed ID: 15112276 [TBL] [Abstract][Full Text] [Related]